Inherited arrhythmia syndrome predisposing to sudden cardiac death

키워드

참고문헌 (86)

1. Huikuri HV, "Sudden death due to cardiac arrhythmias", N Engl J Med, 345, pp.1473~1482 (2001)
2. Maron BJ, "Sudden death in young athletes", N Engl J Med, 349, pp.1064~1075 (2003)
3. Cerrone M, "Genetics of sudden death : focus on inherited channelopathies", Eur Heart J, 32, pp.2109~2118 (2011)
4. Sutherland GR, "Sudden cardiac death : the pro-arrhythmic interaction of an acute loading with an underlying substrate", Eur Heart J, 38, pp.2986~2994 (2017)
5. Robyns T, "Repeat genetic testing with targeted capture sequencing in primary arrhythmia syndrome and cardiomyopathy", Eur J Hum Genet, 25, pp.1313~1323 (2017)
6. John RM, "Ventricular arrhythmias and sudden cardiac death", Lancet, 380, pp.1520~1529 (2012)
7. Prystowsky EN, "Ventricular arrhythmias in the absence of structural heart disease", J Am Coll Cardiol, 59, pp.1733~1744 (2012)
8. 이기홍, "Masked inherited primary arrhythmia syndromes in sudden cardiac death patients accompanied by coronary vasospasm", The Korean Journal of Internal Medicine, 32(5), pp.836~846 (2017), 대한내과학회[DOI]
9. Fishman GI, "Sudden cardiac death prediction and prevention: report from a National Heart, Lung, and Blood Institute and Heart Rhythm Society Workshop", Circulation, 122, pp.2335~2348 (2010)
10. Goldberger JJ, "Risk stratification for arrhythmic sudden cardiac death : identifying the roadblocks", Circulation, 123, pp.2423~2430 (2011)
11. Junttila MJ, "Risk markers of sudden cardiac death in standard 12-lead electrocardiograms", Ann Med, 44, pp.717~732 (2012)
12. 김용철, "Current status of acute myocardial infarction in Korea", The Korean Journal of Internal Medicine, 34(1), pp.1~10 (2019), 대한내과학회[DOI]
13. Albert CM, "Sex differences in cardiac arrest survivors", Circulation, 93, pp.1170~1176 (1996)
14. Hayashi M, "The spectrum of epidemiology underlying sudden cardiac death", Circ Res, 116, pp.1887~1906 (2015)
15. Murakoshi N, "Epidemiology of arrhythmias and sudden cardiac death in Asia", Circ J, 77, pp.2419~2431 (2013)
16. Roh SY, "Abstract 19632 : Inherited cardiac arrhythmias as a cause of sudden cardiac arrest in Korea : a cohort from National Health Insurance Service Database", Circulation, 136(Suppl 1), pp.A19632~ (2017)
17. Roh SY, "Trends in the use of implantable cardioverter-defibrillators for prevention of sudden cardiac arrest : a South Korean nationwide population-based study", Pacing Clin Electrophysiol, 42, pp.1086~1094 (2019)
18. Oh SK, "Genetic testing using next generation sequencing in inherited arrhythmia in the Korean population", pp.2019
19. Priori SG, "The fifteen years of discoveries that shaped molecular electrophysiology : time for appraisal", Circ Res, 107, pp.451~456 (2010)
20. Goldenberg I, "Long QT syndrome", J Am Coll Cardiol, 51, pp.2291~2300 (2008)
21. Patel C, "Short QT syndrome : from bench to bedside", Circ Arrhythm Electrophysiol, 3, pp.401~408 (2010)
22. Roston TM, "The clinical and genetic spectrum of catecholaminergic polymorphic ventricular tachycardia : findings from an international multicentre registry", Europace, 20, pp.541~547 (2018)
23. Priori SG, "2015 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death : The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology(ESC). Endorsed by : Association for European Paediatric and Congenital Cardiology(AEPC)", Eur Heart J, 36, pp.2793~2867 (2015)
24. Kapplinger JD, "Spectrum and prevalence of mutations from the first 2, 500 consecutive unrelated patients referred for the FAMILION long QT syndrome genetic test", Heart Rhythm, 6, pp.1297~1303 (2009)
25. Tester DJ, "Compendium of cardiac channel mutations in 541 consecutive unrelated patients referred for long QT syndrome genetic testing", Heart Rhythm, 2, pp.507~517 (2005)
26. Schwartz PJ, "Long-QT syndrome : from genetics to management", Circ Arrhythm Electrophysiol, 5, pp.868~877 (2012)
27. Schwartz PJ, "Idiopathic long QT syndrome : progress and questions", Am Heart J, 109, pp.399~411 (1985)
28. Priori SG, "Association of long QT syndrome loci and cardiac events among patients treated with beta-blockers", JAMA, 292, pp.1341~1344 (2004)
29. Ahn J, "Effectiveness of beta-blockers depending on the genotype of congenital long-QT syndrome : a meta-analysis", PLoS One, 12, pp.e0185680~ (2017)
30. Mazzanti A, "Interplay between genetic substrate, QTc duration, and arrhythmia risk in patients with long QT syndrome", J Am Coll Cardiol, 71, pp.1663~1671 (2018)
31. 이윤식, "Long QT Syndrome: a Korean Single Center Study", Journal of Korean Medical Science, 28(10), pp.1454~1460 (2013), 대한의학회
32. Burns C, "Clinical and genetic features of Australian families with long QT syndrome : a registry-based study", J Arrhythm, 32, pp.456~461 (2016)
33. Earle N, "Community detection of long QT syndrome with a clinical registry: an alternative to ECG screening programs?", Heart Rhythm, 10, pp.233~238 (2013)
34. Goldenberg I, "Risk for life-threatening cardiac events in patients with genotype-confirmed long-QT syndrome and normal-range corrected QT intervals", J Am Coll Cardiol, 57, pp.51~59 (2011)
35. Sauer AJ, "Long QT syndrome in adults", J Am Coll Cardiol, 49, pp.329~337 (2007)
36. Brugada P, "Brugada syndrome 1992-2012 : 20 years of scientific excitement, and more", Eur Heart J, 34, pp.3610~3615 (2013)
37. Ahn J, "Right ventricular compression mimicking Brugada-like electrocardiogram in a patient with recurrent pectus excavatum", Case Rep Cardiol, 2017, pp.3047937~ (2017)
38. Priori SG, "Natural history of Brugada syndrome : insights for risk stratification and management", Circulation, 105, pp.1342~1347 (2002)
39. Ackerman MJ, "HRS", EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies : this document was developed as a partnership between the Heart Rhythm Society(HRS)and the European Heart Rhythm Association(EHRA), 2011, pp.13, 1077~1109
40. Bezzina CR, "Genetics of sudden cardiac death", Circ Res, 116, pp.1919~1936 (2015)
41. Kusano KF, "Atrial fibrillation in patients with Brugada syndrome relationships of gene mutation, electrophysiology, and clinical backgrounds", J Am Coll Cardiol, 51, pp.1169~1175 (2008)
42. Smits JP, "Genotype-phenotype relationship in Brugada syndrome : electrocardiographic features differentiate SCN5A-related patients from non-SCN5A-related patients", J Am Coll Cardiol, 40, pp.350~356 (2002)
43. Yamagata K, "Genotype-phenotype correlation of SCN5A mutation for the clinical and electrocardiographic characteristics of probands with Brugada syndrome : a Japanese multicenter registry", Circulation, 135, pp.2255~2270 (2017)
44. Sieira J, "Prognostic value of programmed electrical stimulation in Brugada syndrome : 20 years experience", Circ Arrhythm Electrophysiol, 8, pp.777~784 (2015)
45. Delise P, "Risk stratification in individuals with the Brugada type 1 ECG pattern without previous cardiac arrest : usefulness of a combined clinical and electrophysiologic approach", Eur Heart J, 32, pp.169~176 (2011)
46. Probst V, "Long-term prognosis of patients diagnosed with Brugada syndrome : results from the FINGER Brugada Syndrome Registry", Circulation, 121, pp.635~643 (2010)
47. Eckardt L, "Long-term prognosis of individuals with right precordial ST-segment-elevation Brugada syndrome", Circulation, 111, pp.257~263 (2005)
48. Brugada P, "Natural history of Brugada syndrome : the prognostic value of programmed electrical stimulation of the heart", J Cardiovasc Electrophysiol, 14, pp.455~457 (2003)
49. Brugada J, "Long-term follow-up of individuals with the electrocardiographic pattern of right bundle-branch block and ST-segment elevation in precordial leads V1 to V3", Circulation, 105, pp.73~78 (2002)
50. Miyazaki S, "Early repolarization syndrome : a new electrical disorder associated with sudden cardiac death", Circ J, 74, pp.2039~2044 (2010)
51. Wasserburger RH, "The normal RS-T segment elevation variant", Am J Cardiol, 8, pp.184~192 (1961)
52. Klatsky AL, "The early repolarization normal variant electrocardiogram : correlates and consequences", Am J Med, 115, pp.171~177 (2003)
53. Haissaguerre M, "Sudden cardiac arrest associated with early repolarization", N Engl J Med, 358, pp.2016~2023 (2008)
54. Rosso R, "J-point elevation in survivors of primary ventricular fibrillation and matched control subjects : incidence and clinical significance", J Am Coll Cardiol, 52, pp.1231~1238 (2008)
55. Tikkanen JT, "Long-term outcome associated with early repolarization on electrocardiography", N Engl J Med, 361, pp.2529~2537 (2009)
56. Antzelevitch C, "Heterogeneity within the ventricular wall. Electrophysiology and pharmacology of epicardial, endocardial, and M cells", Circ Res, 69, pp.1427~1449 (1991)
57. Yan GX, "Cellular basis for the electrocardiographic J wave", Circulation, 93, pp.372~379 (1996)
58. Yoon N, "Epicardial substrate as a target for radiofrequency ablation in an experimental model of early repolarization syndrome", Circ Arrhythm Electrophysiol, 11, pp.e006511~ (2018)
59. Nademanee K, "Mapping and ablation of ventricular fibrillation associated with early repolarization syndrome", Circulation, 140, pp.1477~1490 (2019)
60. Haissaguerre M, "Ventricular fibrillation with prominent early repolarization associated with a rare variant of KCNJ8", KATP channel, 2009, pp.20, 93~98
61. Di Stolfo G, "Sudden cardiac death in J wave syndrome with short QT associated to a novel mutation in Na v 1. 8 coding gene SCN10A : first case report for a possible pharmacogenomic role", J Electrocardiol, 51, pp.809~813 (2018)
62. Priori SG, "HRS", EHRA, Heart Rhythm, pp.2013, 10[DOI]
63. Visser M, "Idiopathic ventricular fibrillation : the struggle for definition, diagnosis, and follow-up", Circ Arrhythm Electrophysiol, 9, pp.e003817~ (2016)
64. Ingles J, "Concealed arrhythmogenic right ventricular cardiomyopathy in sudden unexplained cardiac death events", Circ Genom Precis Med, 11, pp.e002355~ (2018)
65. Herman AR, "Outcome of apparently unexplained cardiac arrest : results from investigation and follow-up of the prospective cardiac arrest survivors with preserved ejection fraction registry", Circ Arrhythm Electrophysiol, 9, pp.e003619~ (2016)
66. Remme CA, "Diagnosis and long-term follow-up of the Brugada syndrome in patients with idiopathic ventricular fibrillation", Eur Heart J, 22, pp.400~409 (2001)
67. Champagne J, "Recurrent cardiac events in patients with idiopathic ventricular fibrillation, excluding patients with the Brugada syndrome", BMC Med, 3, pp.1~ (2005)
68. Meissner MD, "Ventricular fibrillation in patients without significant structural heart disease : a multicenter experience with implantable cardioverter-defibrillator therapy", J Am Coll Cardiol, 21, pp.1406~1412 (1993)
69. Mewis C, "Late outcome of survivors of idiopathic ventricular fibrillation", Am J Cardiol, 81, pp.999~1003 (1998)
70. Crijns HJ, "Favourable outcome in idiopathic ventricular fibrillation with treatment aimed at prevention of high sympathetic tone and suppression of inducible arrhythmias", Br Heart J, 74, pp.408~412 (1995)
71. Fontaine G, "About the histology of arrhythmogenic right ventricular dysplasia", Circulation, 96, pp.2089~2090 (1997)
72. Corrado D, "Arrhythmogenic right ventricular cardiomyopathy", N Engl J Med, 376, pp.61~72 (2017)
73. McKoy G, "Identification of a deletion in plakoglobin in arrhythmogenic right ventricular cardiomyopathy with palmoplantar keratoderma and woolly hair(Naxos disease)", Lancet, 355, pp.2119~2124 (2000)
74. Huber O, "Structure and function of desmosomal proteins and their role in development and disease", Cell Mol Life Sci, 60, pp.1872~1890 (2003)
75. Gerull B, "Mutations in the desmosomal protein plakophilin-2 are common in arrhythmogenic right ventricular cardiomyopathy", Nat Genet, 36, pp.1162~1164 (2004)
76. Pilichou K, "Mutations in desmoglein-2 gene are associated with arrhythmogenic right ventricular cardiomyopathy", Circulation, 113, pp.1171~1179 (2006)
77. Syrris P, "Arrhythmogenic right ventricular dysplasia", cardiomyopathy associated with mutations in the desmosomal gene desmocollin-2, 2006, pp.79, 978~984
78. Marcus FI, "Right ventricular dysplasia : a report of 24 adult cases", Circulation, 65, pp.384~398 (1982)
79. McGregor SM, "A brief review and update of the clinicopathologic diagnosis of arrhythmogenic cardiomyopathy", Arch Pathol Lab Med, 139, pp.1181~1186 (2015)
80. Thiene G, "Right ventricular cardiomyopathy and sudden death in young people", N Engl J Med, 318, pp.129~133 (1988)
81. Cerrone M, "Missense mutations in plakophilin-2 cause sodium current deficit and associate with a Brugada syndrome phenotype", Circulation, 129, pp.1092~1103 (2014)
82. Corrado D, "Relationship between arrhythmogenic right ventricular cardiomyopathy and Brugada syndrome : new insights from molecular biology and clinical implications", Circ Arrhythm Electrophysiol, 9, pp.e003631~ (2016)
83. Ackerman MJ, "HRS", EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies this document was developed as a partnership between the Heart Rhythm Society(HRS)and the European Heart Rhythm Association(EHRA), 2011, pp.8, 1308~1339
84. Musunuru K, "Genetic testing for inherited cardiovascular diseases : a scientific statement from the American Heart Association", Circ Genom Precis Med, 13, pp.e000067~ (2020)
85. Calkins H, "Risk stratification in arrhythmogenic right ventricular cardiomyopathy", Circulation, 136, pp.2068~2082 (2017)
86. Richards S, "Standards and guidelines for the interpretation of sequence variants : a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology", Genet Med, 17, pp.405~424 (2015)

관련 논문AI추천